Flight crew delayed asking for medical help for man in crisis who later died, lawsuit alleges
A 62-year-old man who suffered an "escalating medical crisis" onboard an American Airlines-affiliated flight died after its crew "delayed requesting medical assistance until after the aircraft had landed, taxied to the gate, and all other passengers had deplaned," a lawsuit says.
The filing against American Airlines and its regional carrier Envoy Air in Colorado federal court is seeking at least $75,000 in damages following the death of John Cannon, a passenger from Kentucky who was traveling to Durango-La Plata County Airport.
"The untimely passing of John William Cannon on April 29, 2023, was the direct and proximate result of the negligence and fault of the Defendants," reads the lawsuit filed this week on behalf of his son.
It claims that American Airlines and Envoy Air "breached their duties of care and were negligent in causing the death" of Cannon by "Failing to give reasonable first aid onboard the aircraft" and "Failing to prioritize John William Cannon in the deboarding process once he exhibited signs of extreme physical distress onboard the aircraft," among other alleged actions.
American Airlines told Fox News Digital, "We are reviewing the complaint."
Attorneys said leading up to his death, Cannon first boarded a plane from Louisville to Dallas and "during the flight, and/or at the time of deboarding, John suffered a syncopal event" -- or loss of consciousness.
"After suffering the event, John was helped to the floor of the jet bridge at Gate 12 in Terminal B of the Dallas Fort Worth International Airport. Two minutes and fifteen seconds later, John was released to make his connecting flight," it continued.
Then on that flight from Dallas to Durango – which was operated by Envoy Air -- Cannon "entered a stage of medical crisis which resulted in him becoming unresponsive," according to the lawsuit.
"Despite Mr. Cannon's escalating medical crisis, the AAL4896 flight crew delayed requesting medical assistance until after the aircraft had landed, taxied to the gate, and all other passengers had deplaned," the lawsuit alleged.
A flight crew member "called emergency services and reported Mr. Cannon as being in and out of consciousness with labored breathing" and "firefighters with Durango La Plata Fire contacted Mr. Cannon and initiated oxygen treatment prior to removing him from the aircraft with members of an EMS team," it added.
"During transport to Mercy Medical Center, Mr. Cannon suffered sinus bradycardia, which progressed to ventricular fibrillation arrest. The ambulance crew performed approximately ten minutes of chest compressions, administered two doses of epinephrine, and delivered multiple Automated External Defibrillator shocks. Despite these interventions, Mr. Cannon did not achieve Return of Spontaneous Circulation," the lawsuit concluded. "The following morning, at 0129 hours, Mr. Cannon was pronounced dead."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
Odor at Charlotte Douglas International Airport sends crew members to hospital
An odor reported at Charlotte Douglas International Airport on Friday sent a number of crew members to the hospital with unspecified injuries, American Airlines said in a statement. Before passengers boarded Flight 2055 on Friday, the odor was reported, the airline said. Crew members received medical attention on site, the airline said, adding that some were taken to the hospital, where they were treated and later released. NBC affiliate WCNC Charlotte reported that seven people were taken to the hospital for treatment. Six people had minor injuries and one person had serious symptoms, the outlet reported. It was not immediately clear what the odor was or where it came from. The nature of the injuries was also not clear, but WCNC reported they were a result of inhaling something. The involved airplane was taken out of service and will be inspected, American Airlines said. This article was originally published on
Yahoo
3 days ago
- Yahoo
Caffeine Flips a Cellular Switch That May Slow Aging, Scientists Discover
We know caffeine is good for an alertness boost first thing in the morning or during an afternoon lull, but researchers have also linked the compound to healthy aging – and a new study takes a close look at some of the cellular mechanisms responsible for that link. Scientists from Queen Mary University of London (QMUL) and the Francis Crick Institute in the UK used fission yeast as stand-ins for human cells, analyzing how doses of caffeine affected the lifespan of the cells and their ability to withstand damage. "These findings help explain why caffeine might be beneficial for health and longevity," says biochemist John-Patrick Alao, from QMUL. "And they open up exciting possibilities for future research into how we might trigger these effects more directly – with diet, lifestyle, or new medicines." Previous research found that caffeine could operate a biological switch called TOR (target of rapamycin), which helps regulate the growth of cells in response to food and energy availability. With the latest experiments, the researchers determined that caffeine doesn't interact directly with TOR. Instead, it controls it through the AMPK pathway, which works kind of like a fuel gauge for cells. We already know that AMPK takes care of some vital jobs in terms of keeping cells running and helping them resist wear and tear more effectively. Now we also know that caffeine has an effect on it. "When your cells are low on energy, AMPK kicks in to help them cope, and our results show that caffeine helps flip that switch," says geneticist and biologist Charalampos Rallis, from QMUL. With caffeine operating the TOR lever through the AMPK enzyme, cells are affected in three different ways, the researchers found: in how they grow, in how they repair their DNA, and in how they respond to stress. That all adds up to cells that stay healthier for longer. When the researchers interrupted the genetic chain reaction that caffeine triggers, the cells didn't get all of the same health benefits – confirmation of how the compound is working, and perhaps, how we might be able to utilize it in the future. The diabetes drug metformin is currently being looked at as a way of keeping us in better shape for a longer period of time, and it too operates through AMPK – suggesting caffeine-based drugs may have a similar effect. Any kind of medication or treatment is still a long way off however, not least because these findings are from yeast cells rather than human cells. The researchers are still keen to learn more about the precise way caffeine interacts with AMPK and TOR. What we can certainly say for now is that more and more studies are showing positive effects from caffeine consumption, whether that's losing body fat, protecting against cardiovascular disease, or keeping dementia at bay. "Direct pharmacological targeting of AMPK may serve towards healthspan and lifespan benefits beyond yeasts, given the highly conserved nature of this key regulatory cellular energy sensor," write the researchers in their published paper. The research has been published in Microbial Cell. People Are Trying Nicotine Gum For Long Covid – Could It Treat Brain Fog? Your Cell's Powerhouses Are Secretly Helping Fight Bacteria, Study Finds Heavy Drinkers Face Higher Risk of Brain Lesions And Alzheimer's Markers
Yahoo
3 days ago
- Yahoo
Your morning coffee could help you stay young — but there's a catch
Could coffee be the liquid key to longevity? A new study reports that the world's most widely used stimulant can extend lifespan and affect how cells respond to genetic damage — though there's a potential complication. A team of researchers at Queen Mary University of London confirms that caffeine interacts with the systems that influence aging, DNA response and cellular stress. The team studied fission yeast, a single-celled organism that is analogous to human cells and uses similar pathways to manage energy, DNA repair and stress. Researchers measured the response of fission yeast to different forms of cellular stress, including DNA damage, toxic exposure and nutrient deprivation. Then they added caffeine to gauge how cells would respond. They found that while caffeine extended the lifespan of yeast, it also affected how cells responded to stress, particularly when the molecular systems that regulate stress were already activated. The findings were published this week in the journal Microbial Cell. The research team previously established that caffeine supports the longevity of cells by activating TOR (target of rapamycin), a biological switch that determines when cells should grow based on the availability of food and energy. According to the team, the TOR switch has been actively controlling energy and stress responses in living things for over 500 million years. In this latest study, the team learned that caffeine doesn't directly activate TOR, but rather influences it by activating AMPK, a cellular fuel reserve in yeast and humans. 'When your cells are low on energy, AMPK kicks in to help them cope,' said study senior author Charalampos (Babis) Rallis. 'And our results show that caffeine helps flip that switch.' The yeast model demonstrated that caffeine's influence on flipping that switch directly impacts how cells grow, repair their DNA and respond to stress — all of which relate to aging. Quite surprisingly, the team found that rather than protecting damaged DNA, caffeine amplified the damage. Typically, when a cell detects DNA damage, it stops dividing to repair it. However, researchers found that caffeine overrides this stop, allowing unhealed cells to continue dividing and making them more vulnerable to future damage. The team assured that this doesn't make your morning cup inherently dangerous. Caffeine's ability to alter how cells respond to problems can be positive or negative, depending on the situation. The team noted that the benefits of caffeine depend on the presence of specific proteins and pathways. The fact that caffeine's effects are neither universal nor automatic may help explain why previous studies exploring the link between caffeine and improved health have been inconsistent. 'These findings help explain why caffeine might be beneficial for health and longevity,' said John-Patrick Alao, the postdoctoral research scientist leading this study. 'And they open up exciting possibilities for future research into how we might trigger these effects more directly — with diet, lifestyle or new medicines.' The team acknowledged that because the study relied only on fission yeast, the findings may not directly translate to human cells. Coffee has long been lauded for its health benefits. Rich in antioxidants, it may enhance brain function. It's also been shown to increase alertness, aid in weight management, boost mood and potentially lower the risk of Type 2 diabetes and heart disease. A 2018 study of nearly half a million British adults found that coffee drinkers had a slightly lower risk of death over 10 years than abstainers. Other research, encompassing more than 170,000 adults in the UK, proposed that those who drink between two and four daily cups of coffee, regardless of whether they have added sugar, live longer than those who don't drink coffee. A 2025 study led by researchers at Tulane University tied a morning brew to lower mortality rates than espresso later in the day. And three to five cups a day at midlife was associated with a decreased risk of Alzheimer's disease later in life, research determined. In addition to Alzheimer's, some studies found that java junkies have up to a 60% lower risk of Parkinson's disease. The more coffee they drank, the lower the risk.
